This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2017 Oct;32(10):1343-1344.

doi: 10.1002/mds.27179. Epub 2017 Sep 18.

A glimmer of light at the end of the tunnel?

Affiliations

Affiliation

¹ Neurodegenerative Diseases Research Group, Institute of Pharmaceutical Sciences, Faculty of Health Sciences and Medicine, King's College, London, United Kingdom.

PMID: 28921664
DOI: 10.1002/mds.27179

Editorial

A glimmer of light at the end of the tunnel?

Peter Jenner. Mov Disord. 2017 Oct.

. 2017 Oct;32(10):1343-1344.

doi: 10.1002/mds.27179. Epub 2017 Sep 18.

Author

Affiliation

¹ Neurodegenerative Diseases Research Group, Institute of Pharmaceutical Sciences, Faculty of Health Sciences and Medicine, King's College, London, United Kingdom.

PMID: 28921664
DOI: 10.1002/mds.27179

No abstract available

PubMed Disclaimer

Comment on

Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease.
Trezzi JP, Galozzi S, Jaeger C, Barkovits K, Brockmann K, Maetzler W, Berg D, Marcus K, Betsou F, Hiller K, Mollenhauer B. Trezzi JP, et al. Mov Disord. 2017 Oct;32(10):1401-1408. doi: 10.1002/mds.27132. Epub 2017 Aug 26. Mov Disord. 2017. PMID: 28843022

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information